A Phase II Randomized, Placebo-Controlled, Double-Blinded Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification in Patients With Moderate Calcific Aortic Valve Stenosis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Ataciguat (Primary)
- Indications Aortic valve stenosis
- Focus Therapeutic Use
- 08 May 2017 Planned End Date changed from 1 May 2017 to 1 Jul 2018.
- 08 May 2017 Planned primary completion date changed from 1 May 2017 to 30 Sep 2017.
- 08 May 2017 Status changed from recruiting to active, no longer recruiting.